Livzon Pharmaceutical Group Inc. (002393.SZ) announced an increase in profit forecast, expecting a net profit attributable to the parent company of 3.3 billion to 3.55 billion yuan in the first half of the year, a year-on-year growth of 222.42%-246.85%.

Zhijong Financial APP News: Lisheng Pharmaceutical (002393.SZ) disclosed its performance forecast for the first half of 2025. The company expects a net profit attributable to shareholders of listed companies to be between 3.3 billion and 3.55 billion yuan, an increase of 222.42% to 246.85% year-on-year; net profit after deducting non-recurring gains and losses is expected to be between 1 billion and 1.15 billion yuan, an increase of 0.83% to 15.95% year-on-year.